Skip to content

Clinical trials

Thyroid Cancer, Papillary trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Cancer, Papillary Country / region: Italy Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20061
20131
20151
20162
20172
20181
20192
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting5
Completed5
Unknown status4
Approved for marketing1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Hoffmann-La Roche3
Istituto Auxologico Italiano2
University of Roma La Sapienza2
Eleonora Lori, MD1
Exelixis1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
Genzyme, a Sanofi Company1
University of Cagliari1
University of Salerno1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Cancer, Papillary16
Carcinoma, Medullary6
Thyroid Neoplasms6
Carcinoma, Non-Small-Cell Lung5
Breast Neoplasms4
Colonic Neoplasms4
Head and Neck Neoplasms4
Adenocarcinoma, Follicular3
Bronchial Neoplasms3
Carcinoma, Bronchogenic3

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.